Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical standards for the management of adverse effects during treatment for TB.
Singh KP, Carvalho ACC, Centis R, D Ambrosio L, Migliori GB, Mpagama SG, Nguyen BC, Aarnoutse RE, Aleksa A, van Altena R, Bhavani PK, Bolhuis MS, Borisov S, van T Boveneind-Vrubleuskaya N, Bruchfeld J, Caminero JA, Carvalho I, Cho JG, Davies Forsman L, Dedicoat M, Dheda K, Dooley K, Furin J, García-García JM, Garcia-Prats A, Hesseling AC, Heysell SK, Hu Y, Kim HY, Manga S, Marais BJ, Margineanu I, Märtson AG, Munoz Torrico M, Nataprawira HM, Nunes E, Ong CWM, Otto-Knapp R, Palmero DJ, Peloquin CA, Rendon A, Rossato Silva D, Ruslami R, Saktiawati AMI, Santoso P, Schaaf HS, Seaworth B, Simonsson USH, Singla R, Skrahina A, Solovic I, Srivastava S, Stocker SL, Sturkenboom MGG, Svensson EM, Tadolini M, Thomas TA, Tiberi S, Trubiano J, Udwadia ZF, Verhage AR, Vu DH, Akkerman OW, Alffenaar JWC, Denholm JT. Singh KP, et al. Among authors: akkerman ow. Int J Tuberc Lung Dis. 2023 Jul 1;27(7):506-519. doi: 10.5588/ijtld.23.0078. Int J Tuberc Lung Dis. 2023. PMID: 37353868 Free PMC article.
High Prevalence of Infectious Diseases and Drug-Resistant Microorganisms in Asylum Seekers Admitted to Hospital; No Carbapenemase Producing Enterobacteriaceae until September 2015.
Ravensbergen SJ, Lokate M, Cornish D, Kloeze E, Ott A, Friedrich AW, van Hest R, Akkerman OW, de Lange WC, van der Werf TS, Bathoorn E, Stienstra Y. Ravensbergen SJ, et al. Among authors: akkerman ow. PLoS One. 2016 May 4;11(5):e0154791. doi: 10.1371/journal.pone.0154791. eCollection 2016. PLoS One. 2016. PMID: 27144599 Free PMC article.
The pharmacokinetics of antibiotics in cystic fibrosis.
Akkerman-Nijland AM, Akkerman OW, Grasmeijer F, Hagedoorn P, Frijlink HW, Rottier BL, Koppelman GH, Touw DJ. Akkerman-Nijland AM, et al. Among authors: akkerman ow. Expert Opin Drug Metab Toxicol. 2021 Jan;17(1):53-68. doi: 10.1080/17425255.2021.1836157. Epub 2020 Dec 29. Expert Opin Drug Metab Toxicol. 2021. PMID: 33213220 Review.
Microevolution of Mycobacterium tuberculosis in a tuberculosis patient.
Al-Hajoj SA, Akkerman O, Parwati I, al-Gamdi S, Rahim Z, van Soolingen D, van Ingen J, Supply P, van der Zanden AG. Al-Hajoj SA, et al. J Clin Microbiol. 2010 Oct;48(10):3813-6. doi: 10.1128/JCM.00556-10. Epub 2010 Aug 4. J Clin Microbiol. 2010. PMID: 20686077 Free PMC article.
Rifampicin and moxifloxacin for tuberculous meningitis.
Akkerman O, Pranger A, van Altena R, van der Werf T, Alffenaar JW. Akkerman O, et al. Lancet Infect Dis. 2013 Jul;13(7):568-9. doi: 10.1016/S1473-3099(13)70101-4. Lancet Infect Dis. 2013. PMID: 23809221 No abstract available.
Drug concentration in lung tissue in multidrug-resistant tuberculosis.
Akkerman OW, van Altena R, Klinkenberg T, Brouwers AH, Bongaerts AH, van der Werf TS, Alffenaar JW. Akkerman OW, et al. Eur Respir J. 2013 Dec;42(6):1750-2. doi: 10.1183/09031936.00047413. Eur Respir J. 2013. PMID: 24293422 Free article. No abstract available.
153 results